XLO XILIO THERAPEUTICS INC Management Changes 8-K Filing 2023 - Appointment of Chief Operating Officer Xilio Therapeutics, Inc. appointed Christopher Frankenfield as Chief Operating Officer, with an annualized base salary of $500,000 and an option to purchase 150,000 shares of the company's common stock.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC